Both in Pharmaceuticals
Rapport Therapeutics vs AnaptysBio
Over the past year RAPP returned −5.6% and ANAB returned +32.4%; their daily moves had a correlation of 0.25.
RAPP −5.6% ANAB +32.4%Growth of $1, one year, split-adjusted
| Metric | RAPP | ANAB |
|---|---|---|
| Price | $25.44 | $47.73 |
| Market cap | $1.43B | $1.43B |
| Today | +1.23% | +1.75% |
| 1 month | −21.0% | −3.0% |
| 6 months | −28.5% | −31.1% |
| Year to date | −16.2% | −1.5% |
| 1 year | −12.1% | +30.5% |
| Revenue growth (YoY) | — | −8.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −206.9% |
| P/E (TTM) | — | — |
| Price / sales | 71.6× | 6.1× |
| Net cash | $436.1M | $286.5M |
| Dividend yield | — | — |
| Volatility (60d) | 79.5% | 41.0% |
| Short % of float | 10.9% | 30.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).